Skip to main content
Cancer Explained
Donate
Beginner 5 min readSource checked

Questions to Ask About Multiple myeloma Treatment

A practical question list for multiple myeloma treatment decisions, including goals, timing, side effects, second opinions, and trials.

NCI source

NCI PDQ - Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (Patient Version)

Two women sit at a table organizing pill bottles and medication
Two women sit at a table organizing pill bottles and medication

Key fact

Active disease is marked by set findings: calcium more than 1 mg/dL above normal, creatinine over 2 mg/dL, hemoglobin under 10.0 g/dL, bone lesions, 60 percent or more marrow plasma cells, or a free light chain ratio of 100 or more with the involved light chain at 100 mg/L or above.

The short answer

Not every plasma cell problem is treated. A published checklist separates MGUS and smoldering myeloma from active disease, using calcium, creatinine, hemoglobin, bone lesions, marrow plasma cells and the free light chain measurements.

  • Active disease is marked by set findings: calcium more than 1 mg/dL above normal, creatinine over 2 mg/dL, hemoglobin under 10.0 g/dL, bone lesions, 60 percent or more marrow plasma cells, or a free light chain ratio of 100 or more with the involved light chain at 100 mg/L or above.

  • Serum albumin and beta-2-microglobulin are both named as independent markers of outlook, so ask for the numbers rather than the summary.

  • If a skeletal survey shows nothing, whole-body scanning and MRI of the spine and pelvis perform about equally in finding bone lesions.

  • Whether to have an autologous transplant is a separate question from when stem cells are collected; cells can be collected now even if the transplant waits.

Choose how you want to understand this

The full explanation.

Do you need treatment yet?

Not every plasma cell problem is treated. NCI separates MGUS, then smoldering myeloma, then active myeloma that needs treatment. MGUS usually causes no symptoms and is watched rather than treated, but it is not nothing: a small risk of progressing to myeloma continues for life, and it is occasionally linked to kidney, nerve or bone problems of its own. That is why it comes with a follow-up schedule instead of a discharge.

The line between them is drawn by a published checklist. NCI lists the findings that mean active disease. Calcium more than 1 mg/dL above the normal range. Creatinine over 2 mg/dL, or creatinine clearance under 40. Anemia with hemoglobin under 10.0 g/dL. One or more bone lesions on imaging. Plasma cells at 60 percent or more in the marrow. A free light chain ratio of 100 or more, provided the involved light chain itself measures at least 100 mg/L. More than one focal spot of at least 5 mm on scanning.

Ask which of those apply to you. If none do, ask what the plan for watching looks like.

The tests that set the plan

NCI lists what is measured at diagnosis. Serum albumin and beta-2-microglobulin are both named as independent markers of outlook.

Imaging matters too. If a skeletal survey shows nothing, NCI describes whole-body scanning or MRI of the spine and pelvis, and says the two perform about equally in finding bone lesions.

If amyloid is suspected, NCI describes a fat pad needle sample and staining the marrow biopsy as the easiest and safest confirmation.

Ask for your numbers, not just the summary. They become the baseline everything later is compared against.

Chromosome testing on the marrow

NCI's summary covers FISH and other chromosome studies on the bone marrow sample. These help sort risk and can shape drug choice.

Ask what your marrow showed, in plain words. Ask what it means for the plan rather than for the statistics.

Transplant, and when stem cells are collected

Autologous stem cell transplant means your own cells are collected, then given back after high-dose treatment. NCI covers it in depth for people fit enough.

The timing question is separate from the doing question. Ask whether cells should be collected now even if the transplant itself waits.

Choosing the first drug combination

NCI describes combinations built around bortezomib and lenalidomide, with daratumumab added. It cites trials testing exactly that addition in newly diagnosed disease.

Ask whether you are getting three drugs or four, and why that choice for you.

Bones and kidneys need attention now

Myeloma can damage kidneys through high calcium, amyloid or light chains. NCI names all three routes.

Bones weakened by myeloma may need treatment before anything else starts. Ask whether any of yours is at risk of breaking.

Questions for the myeloma visit

  • Do I have active myeloma, or something we watch?
  • Which of the active-disease findings do I have?
  • What did my marrow biopsy and chromosome tests show?
  • What are my albumin and beta-2-microglobulin?
  • Am I a transplant candidate, and should cells be collected now?
  • Will my first treatment be three drugs or four?
  • Do any of my bones need treating before we start?

When to get help sooner

Myeloma affects bone, kidneys and blood counts, so a few symptoms need action faster than a routine call.

  • Call 911 or go to an emergency department if you develop new weakness or numbness in both legs, a band of pain around your chest or back, or new trouble controlling your bladder or bowels. That combination can mean pressure on the spinal cord, and hours matter. Go straight to emergency care as well for sudden severe back pain after a minor movement, heavy bleeding, or sudden breathlessness or chest pain.
  • Call your myeloma team at once, day or night, if you have a temperature of 100.4 °F (38 °C) or higher while receiving chemotherapy, and go to an emergency department if you cannot reach them quickly. The CDC describes fever during chemotherapy as a medical emergency, not something to leave on an answering machine.
  • Call your care team the same day if you feel unusually confused, drowsy, thirsty or nauseated, or you are passing much less urine. These can point to a high calcium level or failing kidneys.
  • Call your care team within a day or two if bone pain is steadily building, you are newly short of breath on stairs, or infections keep coming back.

Cancer Staging and Biomarker Testing explain the terms used in a multiple myeloma treatment discussion. Clinical Trial vs Standard Treatment, Palliative Care, and Questions to Ask Your Doctor help you prepare for the multiple myeloma appointment itself.

Where this comes from

These questions were drawn from current patient guidance for multiple myeloma:

Words to know

Tap any term to see what it means.

Browse the full glossary →

A man sits on a couch looking thoughtfully at a tablet at home

Common questions

Do I need treatment right away?

Not always. MGUS and smoldering myeloma are watched rather than treated, though watching is lifelong because the risk of progression never quite goes away. Ask which of the active-disease findings apply to you, and if none do, ask what the watching plan looks like and how often.

What does the marrow biopsy add?

It gives the plasma cell percentage plus FISH and other chromosome studies. Those help sort risk and can shape drug choice. Ask what yours showed in plain words.

Could my kidneys or bones need attention before treatment starts?

Yes. Myeloma can damage kidneys through high calcium, amyloid or light chains, and weakened bones may need treating first. Ask whether any of yours is at risk of breaking.

Which symptoms cannot wait?

New weakness or numbness in both legs, a band of pain around the chest or back, or new trouble controlling bladder or bowels mean calling 911, because hours matter. A temperature of 100.4 °F or higher during chemotherapy is also an emergency.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Your next step

Turn this topic into questions for your next appointment.

Build a question list
Human Connection Layer

Speak With Trained Specialists & Human Navigators

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.

Help Us Improve This Guide

Did this explanation answer your question and help you determine your next step?

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Sources last checked: 2026-08-13 what this meansLast updated: 2026-08-19Next planned review: 2027-07-30

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Source checked This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.